Mohsen Safaei, Arash Goodarzi, Fariba Nouri, Ahmad Reza Farmani, S. Kouhpayeh, Zahra Abpeikar
{"title":"Exploring Squalene's Impact on Epidermal Thickening and Collagen\nProduction: Molecular Docking Insights","authors":"Mohsen Safaei, Arash Goodarzi, Fariba Nouri, Ahmad Reza Farmani, S. Kouhpayeh, Zahra Abpeikar","doi":"10.2174/0115743624288465240307062332","DOIUrl":null,"url":null,"abstract":"\n\nAging is a progressive deterioration characterized by the gradual buildup\nof physiological alterations as time passes. The aging phenomenon encompasses various interconnected\nsystems within the body, such as the skin, bones, cartilage, and hair.\n\n\n\nIn this study, based on the appropriate properties of squalene, including\nantioxidant, anti-inflammatory, and skin repair properties, a molecular docking study was designed\nfor the drug squalene and proteins related to the dermis and epidermis pathway and collagen\nproduction (including Col3A1, Col1A2, FBN1, Decorin, and HAS2).\n\n\n\nThe docking results indicated that the interaction of squalene with hyaluronan\nsynthetase 2 (HAS2) possessed the highest negative binding free energy value of -10.90\nKCal/mol, followed by decorin with a value of -9.99 KCal/mol. Also, the inhibition constant values\nof squalene- HAS2 and squalene-decorin complexes were equal to 1.61 and 7.51 μM, respectively.\nIt has been stated that decorin (as a small proteoglycan) and HAS2 are involved in controlling\nthe assembly of skin fibrils and the biosynthesis of glucosaminoglycans, respectively.\n\n\n\nConsidering that proteoglycans and glucosaminoglycans play a role in the skin aging\nprocess, squalene may be used as an anti-aging agent to induce these pathways and for different\npurposes. Squalene may be used as a potential agent alone or in combination with other\ncompounds in tissue engineering scaffolds for cosmetic, anti-aging, wound healing, and tissue\nrepair applications.\n","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":"25 40","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Signal Transduction Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115743624288465240307062332","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Aging is a progressive deterioration characterized by the gradual buildup
of physiological alterations as time passes. The aging phenomenon encompasses various interconnected
systems within the body, such as the skin, bones, cartilage, and hair.
In this study, based on the appropriate properties of squalene, including
antioxidant, anti-inflammatory, and skin repair properties, a molecular docking study was designed
for the drug squalene and proteins related to the dermis and epidermis pathway and collagen
production (including Col3A1, Col1A2, FBN1, Decorin, and HAS2).
The docking results indicated that the interaction of squalene with hyaluronan
synthetase 2 (HAS2) possessed the highest negative binding free energy value of -10.90
KCal/mol, followed by decorin with a value of -9.99 KCal/mol. Also, the inhibition constant values
of squalene- HAS2 and squalene-decorin complexes were equal to 1.61 and 7.51 μM, respectively.
It has been stated that decorin (as a small proteoglycan) and HAS2 are involved in controlling
the assembly of skin fibrils and the biosynthesis of glucosaminoglycans, respectively.
Considering that proteoglycans and glucosaminoglycans play a role in the skin aging
process, squalene may be used as an anti-aging agent to induce these pathways and for different
purposes. Squalene may be used as a potential agent alone or in combination with other
compounds in tissue engineering scaffolds for cosmetic, anti-aging, wound healing, and tissue
repair applications.
期刊介绍:
In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.
The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.